术前糖化血红蛋白对糖尿病患者非体外循环冠脉搭桥早期结局的影响
该回顾性队列研究纳入2005至2017年703例接受非体外循环冠脉搭桥(OPCAB)的糖尿病患者,按术前HbA1c分为<7.0%与≥7.0%两组,围术期血糖控制目标为<180 mg/dL。
要点
- 术前HbA1c≥7.0%与OPCAB术后主要并发症复合终点风险升高相关。
- 围术期血糖变异性(CV)及时间加权平均血糖≥200 mg/dL未显示与不良结局独立相关。
- 围术期血糖控制目标<180 mg/dL可能削弱围术期血糖指标对结局的影响。
核心结论
- 术前HbA1c≥7.0%反映长期血糖控制不佳,对OPCAB糖尿病患者早期结局产生不良影响。
- 在围术期血糖目标<180 mg/dL下,围术期血糖变异性等指标对结局的影响似乎被削弱。
研究设计与样本
- 回顾性队列研究,纳入2005至2017年接受OPCAB的703例糖尿病患者。
- 按术前HbA1c水平分为<7.0%和≥7.0%两组,围术期血糖控制目标为<180 mg/dL。
- 围术期血糖变异性用变异系数(CV)评估,主要终点为术后永久性卒中、延长通气、深部胸骨伤口感染、肾衰竭、再手术和30天死亡的复合终点。
主要发现
- HbA1c≥7.0%组围术期时间加权平均血糖浓度更高,但CV无差异。
- 多因素logistic回归显示充血性心力衰竭、慢性肾脏病、中度及以上二尖瓣反流、术前血红蛋白水平和术前HbA1c≥7.0%与复合终点独立相关,而围术期CV和时间加权平均血糖≥200 mg/dL不独立相关。
临床怎么用
- 对接受OPCAB的糖尿病患者,术前应关注HbA1c水平,HbA1c≥7.0%提示需优化长期血糖控制以改善早期结局。
- 围术期血糖管理可采用<180 mg/dL的目标,该目标下血糖变异性对结局的影响可能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There seem to be modifiable components of diabetes in terms of glycemic control to improve surgical outcome. The aim of the study was to evaluate impact of preoperative glycated hemoglobin (HbA1c) level in patients with diabetes mellitus undergoing off-pump coronary bypass (OPCAB) on perioperative glycemic variability and short-term outcome. METHODS: Medical records of 703 patients with diabetes mellitus who underwent OPCAB from 2005 to 2017 were reviewed. The perioperative goal of glycemic control was <180 mg/dL. Patients were divided into 2 groups according to HbA1c level (<7.0% or ≥7.0%). Glycemic variability during surgery and up to 24 hours after surgery was assessed by coefficient of variation (CV). Primary outcome was defined as composite of postoperative permanent stroke, prolonged ventilation, deep sternal wound infection, renal failure, reoperation, and 30-day mortality. RESULTS: Incidence of composite of postoperative morbidity and mortality endpoints was greater in patients with HbA1c ≥7.0% (21% vs 15%, P = .041). Perioperative time-weighted average glucose concentration was also greater in patients with HbA1c ≥7.0%, whereas the CV did not show any difference. Multivariable logistic regression analysis revealed that congestive heart failure, chronic kidney disease, moderate mitral regurgitation or greater, preoperative hemoglobin level, and preoperative HbA1c ≥7.0% were independently associated with composite of postoperative morbidity and mortality, but perioperative CV and time-weighted average glucose ≥200 mg/dL were not. CONCLUSIONS: Increased preoperative HbA1c (≥7.0%) level reflecting long-term glycemic control seems to exert an adverse influence on outcome, whereas the influence of perioperative glycemic variables appear to be abrogated using a target glucose level of <180 mg/dL in patients with diabetes mellitus undergoing OPCAB.
引用
- Kim HJ, Shim JK, Youn YN, et al. Influence of preoperative hemoglobin A1c on early outcomes in patients with diabetes mellitus undergoing off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2019. PMID: 30833085. doi:10.1016/j.jtcvs.2019.01.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。